PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free

Novus Biologicals | Catalog # NB300-537

Novus Biologicals
Loading...

Key Product Details

Validated by

Knockout/Knockdown

Species Reactivity

Validated:

Human, Mouse, Rat, Bovine, Rabbit

Cited:

Human, Mouse, Rat, Bovine, Rabbit

Applications

Validated:

Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot, Flow Cytometry, Immunocytochemistry/ Immunofluorescence, Simple Western, Immunoprecipitation, Chromatin Immunoprecipitation (ChIP), Gel Super Shift Assays, Knockdown Validated

Cited:

Immunohistochemistry-Paraffin, Western Blot, Simple Western, Immunoprecipitation, IF/IHC

Label

Unconjugated

Antibody Source

Monoclonal Mouse IgG2B Clone # 3B6/PPAR

Format

BSA Free
Loading...

Product Specifications

Immunogen

Purified recombinant PPAR alpha protein.

Localization

Nuclear

Specificity

PPAR alpha (3B6/PPAR)

Clonality

Monoclonal

Host

Mouse

Isotype

IgG2B

Scientific Data Images for PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free

Flow Cytometry: PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free [NB300-537]

Flow Cytometry: PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free [NB300-537]

Flow Cytometry: PPAR alpha/NR1C1 Antibody (3B6/PPAR) [NB300-537] - An intracellular stain was performed on U-87 cells with PPAR alpha/NR1C1 Antibody [3B6/PPAR] NB300-537AF647 (blue) and a matched isotype control (orange). Cells were fixed with 4% PFA and then permeabilized with 0.1% saponin. Cells were incubated in an antibody dilution of 2.5 ug/mL for 30 minutes at room temperature. Both antibodies were conjugated to Alexa Fluor 647.
Western Blot: PPAR alpha/NR1C1 Antibody (3B6/PPAR)BSA Free [NB300-537]

Western Blot: PPAR alpha/NR1C1 Antibody (3B6/PPAR)BSA Free [NB300-537]

Western Blot: PPAR alpha/NR1C1 Antibody (3B6/PPAR) [NB300-537] - Analysis of 25 ug of Hela (Lane 1), Jurkat (Lane 2), and NIH-3T3 cell lysates (Lane 3) and a molecular weight protein ladder.
Flow Cytometry: PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free [NB300-537]

Flow Cytometry: PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free [NB300-537]

Flow Cytometry: PPAR alpha/NR1C1 Antibody (3B6/PPAR) [NB300-537] - An intracellular stain was performed on Hek293 cells with PPAR alpha/NR1C1 [3B6/PPAR] Antibody NB300-537AF647 (blue) and a matched isotype control (orange). Cells were fixed with 4% PFA and then permeabilized with 0.1% saponin. Cells were incubated in an antibody dilution of 2.5 ug/mL for 30 minutes at room temperature. Both antibodies were conjugated to Alexa Fluor 647.
Western Blot: PPAR alpha/NR1C1 Antibody (3B6/PPAR)BSA Free [NB300-537]

Western Blot: PPAR alpha/NR1C1 Antibody (3B6/PPAR)BSA Free [NB300-537]

Western Blot: PPAR alpha/NR1C1 Antibody (3B6/PPAR) [NB300-537] - 293T cell lysate. Image from verified customer review.
Flow Cytometry: PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free [NB300-537]

Flow Cytometry: PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free [NB300-537]

Flow Cytometry: PPAR alpha/NR1C1 Antibody (3B6/PPAR) [NB300-537] - Analysis of PPAR alpha in Jurkat cells compared to an isotype control (blue).
Flow Cytometry: PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free [NB300-537]

Flow Cytometry: PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free [NB300-537]

Flow Cytometry: PPAR alpha/NR1C1 Antibody (3B6/PPAR) [NB300-537] - Analysis of PPAR alpha in Hela cells compared to an isotype control (blue).
Flow Cytometry: PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free [NB300-537]

Flow Cytometry: PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free [NB300-537]

Flow Cytometry: PPAR alpha/NR1C1 Antibody (3B6/PPAR) [NB300-537] - Analysis of PPAR alpha in 3T3 cells compared to an isotype control (blue).
Flow Cytometry: PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free [NB300-537]

Flow Cytometry: PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free [NB300-537]

Flow Cytometry: PPAR alpha/NR1C1 Antibody (3B6/PPAR) [NB300-537] - An intracellular stain was performed on Jurkat cells with PPAR alpha/NR1C1 Antibody (3B6/PPAR) NB300-537AF647 (blue) and a matched isotype control (orange). Cells were fixed with 4% PFA and then permeabilized with 0.1% saponin. Cells were incubated in an antibody dilution of 5 ug/mL for 30 minutes at room temperature. Both antibodies were conjugated to Alexa Fluor 647.
Knockdown Validated: PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free [NB300-537]

Western Blot: PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free [NB300-537]

Western Blot: PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free [NB300-537] - PPAR alpha/NR1C1 was knocked down with siRNA in primary cultured rat cardiomyocytes. Image from verified customer review.
PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free

Western Blot: PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free [NB300-537] -

The metabolic remodeling process in natural kidney aging. A Representative images of Oil Red O staining in the 24-month-old and 6-month-old group (n = 6), scale bar = 50 μm; B, C the downregulated protein levels of FAO markers (i.e., PPAR alpha, ACOX1, and CPT1A) and upregulated protein levels of glycolysis markers (i.e., HK2 and PDK1) by western blot, and their semi-quantitative analyses (n = 6); D immunostaining for GLIS1 (red) and PPAR alpha (green), with DAPI (blue) counterstaining by IF staining in the 24-month-old and 6-month-old group (n = 6), scale bar = 50 μm; E lactate levels in the 24-month-old and 6-month-old group (n = 6); F the downregulated protein levels of PPAR alpha, ACOX1, and CPT1A, and up-regulated protein levels of HK2 and PDK1 in the 24-month-old group by IHC assay and their semi-quantitative analyses (n = 6), scale bar = 50 μm. The data are expressed as the mean +/- SD of three independent experiments. **P <.01 or ***P <.001 versus the 6-month-old group by Student’s t-test Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/39736678), licensed under a CC-BY license. Not internally tested by Novus Biologicals.
PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free

Western Blot: PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free [NB300-537] -

Bioinformatics analysis of proteomic results.(A). Hierarchical clustering analysis of the differentially expressed proteins in the two groups (si-CD151 vs si-NC) (n = 3) (B) The differentially expressed proteins analyzed by volcano plots between every two groups (si-CD151 vs si-NC) (C) Circus plots of GO Classification Annotation of differential protein. (D) KEGG pathways of differentially expressed proteins. OS: Organismal Systems; M: Metabolism; GIP: Genetic Information Processing; CP: Cellular Processes. (E) Western blot analysis of PPAR-alpha, PCG-1 alpha and GAPDH) in CMs under PE, quantified by Image J (n = 4). (F) Western blot analysis of PPAR-gamma and GAPDH) in CFs under Ang-II, quantified by Image J (n = 4). Data are expressed as mean +/- SEM. Image collected and cropped by CiteAb from the following open publication (https://dx.plos.org/10.1371/journal.pone.0297121), licensed under a CC-BY license. Not internally tested by Novus Biologicals.
PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free

Western Blot: PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free [NB300-537] -

The over-expressed GLIS1 suppressed metabolic remodeling from FAO to glycolysis in the accelerated aging mouse model. A The representative images of mouse kidney tissue in the control, AAV-Vector and AAV-GLIS1 group stained with Oil Red O (n = 6), scale bar = 50 μm; B, C downregulated protein levels of PPAR alpha, ACOX1, and CPT1A in the accelerated aging mouse model were reversed in the presence of AAV-GLIS1, while upregulated protein levels of HK2 and PKD1 in the accelerated aging mouse model were reduced by introducing AAV-GLIS1 (n = 6); D lactate levels in the control, AAV-Vector and AAV-GLIS1 group (n = 6); E the reversed effect of PPAR alpha, ACOX1 and CPT1A levels, as well as HK2 and PDK1 levels in the presence of AAV-GLIS1 by IHC assay, and their semi-quantitative analyses (n = 6), scale bar = 50 μm; F immunostaining for PPAR alpha, ACOX1, CPTA1, HK2, and PDK1 (green), with DAPI (blue) counterstaining by IF staining in accelerated aging mouse model (n = 6), scale bar = 50 μm. The data are expressed as the mean +/- SD of three independent experiments. **P <.01 or ***P <.001 versus the AAV-vector group by one-way ANOVA Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/39736678), licensed under a CC-BY license. Not internally tested by Novus Biologicals.
PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free

Western Blot: PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free [NB300-537] -

The ablation of METTL3 triggered metabolic remodeling and aggravated cell senescence renal fibrosis. A Protein levels of GLIS1, PPAR alpha, ACOX1, CPT1A, HK2, PDK1, FN, alpha -SMA, and P16INK4A by western blot in the vector and siMETTL3 group, and their semi-quantitative analyses (n = 3); B representative images of Oil Red O staining in the vector and siMETTL3 group (n = 3), scale bar = 50 μm; C double immunostaining for GLS1 and PPAR alpha, ACOX1, CPT1A, HK2, PDK1, and alpha -SMA by IF staining (n = 3) scale bar = 50 μm. The data are expressed as the mean +/- SD of three independent experiments. **P <.01 or ***P <.001 versus the vector group by Student’s t-test Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/39736678), licensed under a CC-BY license. Not internally tested by Novus Biologicals.
PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free

Western Blot: PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free [NB300-537] -

CCM treatment upregulates AMPK and PPAR-alpha pathways. (a) Western blot analysis of the expression of AMPK. Densitometric analysis is shown in the bar graph. (b) Western blot analysis of the expressions of PPAR-alpha and PGC-1 alpha. Densitometric analysis is shown in the bar graph. Data are expressed as mean values +/- SD (*P < 0.05 compared with the sham group; #P < 0.05 compared with HF group). Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/35799598), licensed under a CC-BY license. Not internally tested by Novus Biologicals.
PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free

Immunohistochemistry: PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free [NB300-537] -

The metabolic remodeling process in natural kidney aging. A Representative images of Oil Red O staining in the 24-month-old and 6-month-old group (n = 6), scale bar = 50 μm; B, C the downregulated protein levels of FAO markers (i.e., PPAR alpha, ACOX1, and CPT1A) and upregulated protein levels of glycolysis markers (i.e., HK2 and PDK1) by western blot, and their semi-quantitative analyses (n = 6); D immunostaining for GLIS1 (red) and PPAR alpha (green), with DAPI (blue) counterstaining by IF staining in the 24-month-old and 6-month-old group (n = 6), scale bar = 50 μm; E lactate levels in the 24-month-old and 6-month-old group (n = 6); F the downregulated protein levels of PPAR alpha, ACOX1, and CPT1A, and up-regulated protein levels of HK2 and PDK1 in the 24-month-old group by IHC assay and their semi-quantitative analyses (n = 6), scale bar = 50 μm. The data are expressed as the mean +/- SD of three independent experiments. **P <.01 or ***P <.001 versus the 6-month-old group by Student’s t-test Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/39736678), licensed under a CC-BY license. Not internally tested by Novus Biologicals.
PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free

Immunohistochemistry: PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free [NB300-537] -

The over-expressed GLIS1 suppressed metabolic remodeling from FAO to glycolysis in the accelerated aging mouse model. A The representative images of mouse kidney tissue in the control, AAV-Vector and AAV-GLIS1 group stained with Oil Red O (n = 6), scale bar = 50 μm; B, C downregulated protein levels of PPAR alpha, ACOX1, and CPT1A in the accelerated aging mouse model were reversed in the presence of AAV-GLIS1, while upregulated protein levels of HK2 and PKD1 in the accelerated aging mouse model were reduced by introducing AAV-GLIS1 (n = 6); D lactate levels in the control, AAV-Vector and AAV-GLIS1 group (n = 6); E the reversed effect of PPAR alpha, ACOX1 and CPT1A levels, as well as HK2 and PDK1 levels in the presence of AAV-GLIS1 by IHC assay, and their semi-quantitative analyses (n = 6), scale bar = 50 μm; F immunostaining for PPAR alpha, ACOX1, CPTA1, HK2, and PDK1 (green), with DAPI (blue) counterstaining by IF staining in accelerated aging mouse model (n = 6), scale bar = 50 μm. The data are expressed as the mean +/- SD of three independent experiments. **P <.01 or ***P <.001 versus the AAV-vector group by one-way ANOVA Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/39736678), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

Applications for PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free

Application
Recommended Usage

Chromatin Immunoprecipitation (ChIP)

1:10-1:500

Flow Cytometry

1 ug / 10^6 cells

Gel Super Shift Assays

1:1 - 1:100

Immunocytochemistry/ Immunofluorescence

2 ug/ml

Immunohistochemistry

1:10 - 1:500

Immunohistochemistry-Paraffin

1:200

Immunoprecipitation

1:10 - 1:500

Simple Western

1:50

Western Blot

2 - 5 ug/ml
Application Notes
May be useful in ChIP. Rabbit-IP reported in publication, see Sumanasekera WK et al. Rat-IHC reported in publication, see Crespillo A et al.
See Simple Western Antibody Database for Simple Western validation: Tested in Skin, separated by Size, antibody dilution of 1:50

Reviewed Applications

Read 2 reviews rated 4.5 using NB300-537 in the following applications:

Flow Cytometry Panel Builder

Bio-Techne Knows Flow Cytometry

Save time and reduce costly mistakes by quickly finding compatible reagents using the Panel Builder Tool.

Advanced Features

  • Spectra Viewer - Custom analysis of spectra from multiple fluorochromes
  • Spillover Popups - Visualize the spectra of individual fluorochromes
  • Antigen Density Selector - Match fluorochrome brightness with antigen density
Build Your Panel Now

Formulation, Preparation, and Storage

Purification

Immunogen affinity purified

Formulation

PBS

Format

BSA Free

Preservative

0.05% Sodium Azide

Concentration

1 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at -20C. Avoid freeze-thaw cycles.

Background: PPAR alpha/NR1C1

Peroxisome proliferators are non-genotoxic carcinogens which are purported to exert their effect on cells through their interaction with members of the nuclear hormone receptor family, termed peroxisome proliferator activated receptors (PPARs). Nuclear hormone receptors are ligand-dependent intracellular proteins that stimulate transcription of specific genes by binding to specific DNA sequences following activation by the appropriate ligand. Studies indicate that PPARs are activated by peroxisome proliferators such as clofibric acid, nafenopin, and WY-14,643, as well as by some fatty acids. It has also been shown that PPARs can induce transcription of acyl coenzyme A oxidase & cytochrome P450 A6 (CYP450 A6) through interaction with specific response elements. PPAR alpha is activated by free fatty acids including linoleic, arachidonic, and oleic acids. Induction of peroxisomes by this mechanism leads to a reduction in blood triglyceride levels. PPAR alpha is expressed mainly in skeletal muscle, heart, liver, and kidney and is thought to regulate many genes involved in the beta-oxidation of fatty acids. Activation of rat liver PPAR alpha has been shown to suppress hepatocyte apoptosis. PPAR alpha, like several other nuclear hormone receptors, heterodimerizes with retinoic X receptor (RXR) alpha to form a transcriptionally competent complex. The corresponding gene for the PPAR alpha is NR1C1.

Long Name

Peroxisome Proliferator-activated Receptor alpha

Alternate Names

NR1C1, PPARA

Entrez Gene IDs

5465 (Human); 19013 (Mouse); 25747 (Rat)

Gene Symbol

PPARA

UniProt

Additional PPAR alpha/NR1C1 Products

Product Documents for PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Product Specific Notices for PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Citations for PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free

Customer Reviews for PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free (2)

4.5 out of 5
2 Customer Ratings
5 Stars
50%
4 Stars
50%
3 Stars
0%
2 Stars
0%
1 Stars
0%

Have you used PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

Customer Images


Showing  1 - 2 of 2 reviews Showing All
Filter By:
  • PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free
    Name: Shinichi Oka
    Application: Western Blot
    Sample Tested: primary neonatal ventricular cardiomyocytes
    Species: Rat primary cultured cardiomyocytes and Rat
    Verified Customer | Posted 08/24/2022
    PPARa was knocked down with siRNA in primary cultured rat cardiomyocytes.
    Endogenous PPARa was knocked down with siRNA.
    PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free NB300-537
    Bio-Techne Response
    This review was submitted through the legacy Novus Innovators Program, reflecting a new species or application tested on a primary antibody.
  • Name: Anonymous
    Application: Western Blot
    Sample Tested: Whole cell lysate from 293T cells, in lysis buffer
    Species: Human
    Verified Customer | Posted 10/02/2014
    WB for PPARalpha in 293T cells
    PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free NB300-537

There are no reviews that match your criteria.

Showing  1 - 2 of 2 reviews Showing All

Protocols

Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.

FAQs for PPAR alpha/NR1C1 Antibody (3B6/PPAR) - BSA Free

Showing  1 - 2 of 2 FAQs Showing All
  • Q: Please differentiate to me between PPAR and PGC clearly. I am confused with the difference between these two

    A:

    Thank you very much for contacting Novus Biologicals technical support team and sharing your query on the differences between PGC-1 alpha and PPAR. These are two different proteins encoded by their respective genes and serves different functions. PGC-1 alpha (PGC1A or PPAR gamma coactivator 1-alpha) is a transcriptional co-activator for steroid receptors and nuclear receptors, and it regulates diverse aspects of cellular physiology. It up-regulates the transcriptional activity of PPAR-gamma /thyroid hormone receptor on the uncoupling protein promoter; regulates the key mitochondrial genes involved in adaptive thermogenesis; implicates in the metabolic reprogramming in response to nutrients availability through the coordination of the expression of a wide array of genes involved in the regulation of glucose and fatty acid metabolism. Among our PGC-1 alpha antibodies, NBP1-04676 is our best selling product with nice customer feedback and citations in at least 13 research publications. PPAR (PPAR alpha) on the other hand is a ligand-activated transcription factor which gets activated by the endogenous ligand 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine, and oleylethanolamide (a naturally occurring lipid that regulates satiety), and acts as a key regulator of lipid metabolism. It also acts as a receptor for peroxisome proliferators such as hypolipidemic drugs and fatty acids. It regulates the peroxisomal beta-oxidation pathway of fatty acids, and also functions as transcription activator for the ACOX1 and P450 genes. We have a variety of PPAR alpha antibodies. I hope you will find this information helpful but please let me know if I can support you with anything else from my end. Thank you very much for choosing Novus Biologicals as your quality reagent supplier and we wish you the best with your research projects.

  • Q: Would you so kind to let me have protocol of product which cat have cat number NB300-537?

    A:

    We do not have any protocols specifically for product NB300-537. However, we do have some publications listed for this product on the datasheet under the "Images, Reviews & Publications" tab. Furthermore, our general protocols for a range of antibody applications can be found using this link.

  • Q: Please differentiate to me between PPAR and PGC clearly. I am confused with the difference between these two

    A:

    Thank you very much for contacting Novus Biologicals technical support team and sharing your query on the differences between PGC-1 alpha and PPAR. These are two different proteins encoded by their respective genes and serves different functions. PGC-1 alpha (PGC1A or PPAR gamma coactivator 1-alpha) is a transcriptional co-activator for steroid receptors and nuclear receptors, and it regulates diverse aspects of cellular physiology. It up-regulates the transcriptional activity of PPAR-gamma /thyroid hormone receptor on the uncoupling protein promoter; regulates the key mitochondrial genes involved in adaptive thermogenesis; implicates in the metabolic reprogramming in response to nutrients availability through the coordination of the expression of a wide array of genes involved in the regulation of glucose and fatty acid metabolism. Among our PGC-1 alpha antibodies, NBP1-04676 is our best selling product with nice customer feedback and citations in at least 13 research publications. PPAR (PPAR alpha) on the other hand is a ligand-activated transcription factor which gets activated by the endogenous ligand 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine, and oleylethanolamide (a naturally occurring lipid that regulates satiety), and acts as a key regulator of lipid metabolism. It also acts as a receptor for peroxisome proliferators such as hypolipidemic drugs and fatty acids. It regulates the peroxisomal beta-oxidation pathway of fatty acids, and also functions as transcription activator for the ACOX1 and P450 genes. We have a variety of PPAR alpha antibodies. I hope you will find this information helpful but please let me know if I can support you with anything else from my end. Thank you very much for choosing Novus Biologicals as your quality reagent supplier and we wish you the best with your research projects.

  • Q: Would you so kind to let me have protocol of product which cat have cat number NB300-537?

    A:

    We do not have any protocols specifically for product NB300-537. However, we do have some publications listed for this product on the datasheet under the "Images, Reviews & Publications" tab. Furthermore, our general protocols for a range of antibody applications can be found using this link.

Showing  1 - 2 of 2 FAQs Showing All
View all FAQs for Antibodies
Loading...